News
NUVB-WS
0.2800
0.00%
0.0000
Weekly Report: what happened at NUVB WS last week (0415-0419)?
Weekly Report · 5d ago
NUVATION BIO INC <NUVB.N>: RBC RAISES TARGET PRICE TO $5 FROM $4
Reuters · 04/17 09:56
Weekly Report: what happened at NUVB WS last week (0408-0412)?
Weekly Report · 04/15 09:18
Weekly Report: what happened at NUVB WS last week (0401-0405)?
Weekly Report · 04/08 09:19
Weekly Report: what happened at NUVB WS last week (0325-0329)?
Weekly Report · 04/01 09:19
BUZZ-U.S. STOCKS ON THE MOVE-Nuvation Bio, Seagate, AppFolio
Wall Street's main stock indexes climbed on Tuesday. Dow Jones Industrial Average was up 0.21% at 39,395.24. Most heavyweight growth stocks and chipmakers rose. Nuvation Bio, Seagate, AppFolio among the top percentage gainers.
Reuters · 03/26 17:57
BUZZ-U.S. STOCKS ON THE MOVE-Reddit, CONSOL Energy, Nuvation Bio
Dow Jones Industrial Average was up 0.23% on Tuesday. Top three S&P 500 percentage gainers were Seagate Technology, Nuvation Bio and Krispy Kreme. Reddit, Consol Energy and Evercore are among the biggest decliners on the NYSE.
Reuters · 03/26 15:53
BUZZ-Nuvation Bio rises on deal to become commercial organization by 2025
Drug developer Nuvation Bio's shares rise 20% to $2.69. Company agrees to buy cancer therapy developer AnHeart Therapeutics for $270 million. Deal will give co the potential to become a commercial organization by the end of 2025. One of AnHeart's cancer therapies could receive approval as early as 2025.
Reuters · 03/26 14:59
BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, UPS, Dell
U.S. Stock index futures ticked up on Tuesday. Most megacap and chip stocks advanced. Krispy Kreme, UPS, Dell and Newmont rise. Investors readied for more data to assess the Federal Reserve's rate path in a week curtailed by Easter break.
Reuters · 03/26 11:44
Nuvation Bio Inc: Current report
Press release · 03/25 12:18
Weekly Report: what happened at NUVB WS last week (0318-0322)?
Weekly Report · 03/25 09:19
Weekly Report: what happened at NUVB WS last week (0311-0315)?
Weekly Report · 03/18 09:19
Weekly Report: what happened at NUVB WS last week (0304-0308)?
Weekly Report · 03/11 09:19
Nuvation Bio Inc: Statement of changes in beneficial ownership of securities
Press release · 03/04 23:20
Weekly Report: what happened at NUVB WS last week (0226-0301)?
Weekly Report · 03/04 09:19
BRIEF-Nuvation Bio Q4 EPS USD -0.06
Reuters · 02/29 21:01
Weekly Report: what happened at NUVB WS last week (0219-0223)?
Weekly Report · 02/26 09:21
Weekly Report: what happened at NUVB WS last week (0212-0216)?
Weekly Report · 02/19 09:21
Weekly Report: what happened at NUVB WS last week (0205-0209)?
Weekly Report · 02/12 09:19
Weekly Report: what happened at NUVB WS last week (0129-0202)?
Weekly Report · 02/05 09:21
More
Webull provides a variety of real-time NUVB-WS stock news. You can receive the latest news about Nuvation Bio Inc through multiple platforms. This information may help you make smarter investment decisions.
About NUVB-WS
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.